| News and New Technologies from the Buyer's Guide for Life Scientists |
Sponsored by Equitech-Bio
Your Source for High-Quality Serum and Reagents
As a pioneer in serum processing and fractionation methodology, Equitech-Bio remains on the leading edge of performance, accountability and economy. We are a component manufacturer of all animal and human albumins, human and animal sera and plasma, ultrapure IgGs, primary and polyclonal antisera, custom polyclonal and monoclonal antibodies. We have been in business for over twenty years, and we maintain total control and traceability from the site of collection to the final product, and manufacture according to cGMPs.
more...
|
|
|
|
| Featured Article
|
 Spectrophotometry
Spectrophotometry is a technology that has long been considered mature, and advances in instrumentation tend to focus on fine-tuning the technical details, such as...more...
|
|
|
|
|
|
| Promotion
|
Receive a 20% Discount on Hematology Reagents for the Study of Plasmin Activation
For a limited time, Cell Sciences is offering a 20% discount on selected products useful in the investigation of plasmin activation. These include PAI-1, tPA, uPA, uPAR, Vitronectin and related proteins and ELISA kits. Plasminogen Activator Inhibitor 1 (PAI-1) plays a key role in fibrinolysis through its regulation of Tissue-type (tPA) and Urokinase-type Plasminogen Activators (uPA). Plasminogen is the inactive zymogen of plasmin, the protease responsible for degrading fibrin. The intricacies of the PAI-1-Plasminogen Activator-Plasmin system and its regulation are being investigated in renal and cardiovascular disease, in addition to inflammation, angiogenesis, and cancer.More Information
|
|
|
| Events |
|
Pharmacovigilance
March 15 - March 16, 2010
The importance of developing effective pharmacovigilance systems has been fueled by an increased focus on drug safety and the ever-changing regulatory environment. This conference will tackle inspections, risk management, the use of Independent Data Monitoring Committees and establishing relationships with regulatory bodies along with a host of other key topics.
more...
BIT Life Sciences' 2nd Annual World Vaccine Congress 2010
March 24 - March 26, 2010
WCV-2010 is designed to cover almost all areas in frontier of Vaccinology: new technology innovations, vaccine R&D or discovery, regulatory, public health, safety and ethic issues, clinical practices, finance and business development, vaccine manufacturers and Procurement, equipment sellers and buyers, service and consulting providers, enabled technology and ready-to-go product licensing. The congress aims to advance a brainstorm and to promote the updates on today and next generation human and veterinary vaccines.
more...
Asthma & COPD
April 21 - April 22, 2010
This event offer you latest developments in asthma and COPD drug development, including the use of bronchodilators and kinases as well as antibody based biologics. There will also be presentations on optimising respiratory clinical trial data and new therapeutic targets in asthma and COPD.
more...
|
|
|
|
| Back to Top |
|
